LABU vs. BIB

Last updated Jun 23, 2026

LABU (Direxion Daily S&P Biotech Bull 3x Shares) and BIB (ProShares Ultra Nasdaq Biotechnology) are both Leveraged Equities funds - LABU tracks the S&P Biotechnology Select Industry Index (300%) while BIB tracks the NASDAQ Biotechnology Index (200%). Both are passively managed. Over the past 10 years, LABU returned -7.38%/yr vs 9.50%/yr for BIB. Their correlation of 0.92 suggests significant overlap in exposure. LABU charges 1.12%/yr vs 0.95%/yr for BIB.

Performance

LABU vs. BIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Nasdaq Biotechnology (BIB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LABU achieves a 44.31% return, which is significantly higher than BIB's 10.33% return. Over the past 10 years, LABU has underperformed BIB with an annualized return of -7.38%, while BIB has yielded a comparatively higher 9.50% annualized return.

LABU

• 1D: 11.19%
• 1M: 31.29%
• YTD: 44.31%
• 6M: 30.68%
• 1Y: 313.64%
• 3Y*: 22.45%
• 5Y*: -30.40%
• 10Y*: -7.38%

BIB

• 1D: 3.51%
• 1M: 7.37%
• YTD: 10.33%
• 6M: 5.76%
• 1Y: 95.42%
• 3Y*: 18.87%
• 5Y*: -0.66%
• 10Y*: 9.50%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LABU vs. BIB - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LABU Direxion Daily S&P Biotech Bull 3x Shares	44.31%	79.17%	-26.02%	-13.41%	-80.36%	-64.15%	74.66%	75.50%	-57.61%	149.12%
BIB ProShares Ultra Nasdaq Biotechnology	10.33%	59.21%	-9.84%	-1.06%	-28.85%	-6.02%	39.79%	46.71%	-24.93%	40.49%

Correlation

The correlation between LABU and BIB is 0.93, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.93
Correlation (3Y) Calculated over the trailing 3-year period	0.92
Correlation (5Y) Calculated over the trailing 5-year period	0.91
Correlation (10Y) Calculated over the trailing 10-year period	0.92
Correlation (All Time) Calculated using the full available price history since May 28, 2015	0.92

The correlation between LABU and BIB has been stable across timeframes, ranging from 0.91 to 0.93 - a consistent structural relationship.

LABU vs. BIB - Sectors Allocation Comparison

Sectors	LABU	BIB
Healthcare	99.7%	62.9%
Financial Services	0.3%	6.8%
Basic Materials	0.0%	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

LABU vs. BIB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABU

LABU Risk / Return Rank: 90
LABU Sharpe Ratio Rank: 96
LABU Sortino Ratio Rank: 85
LABU Omega Ratio Rank: 76
LABU Calmar Ratio Rank: 97
LABU Martin Ratio Rank: 95

BIB

BIB Risk / Return Rank: 76
BIB Sharpe Ratio Rank: 77
BIB Sortino Ratio Rank: 67
BIB Omega Ratio Rank: 58
BIB Calmar Ratio Rank: 91
BIB Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABU vs. BIB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LABU	BIB	Difference
Sharpe ratio: Return per unit of total volatility	4.01	2.38	+1.64
Sortino ratio: Return per unit of downside risk	3.61	2.97	+0.64
Omega ratio: Gain probability vs. loss probability	1.43	1.35	+0.08
Calmar ratio: Return relative to maximum drawdown	10.29	5.67	+4.62
Martin ratio: Return relative to average drawdown	28.91	17.31	+11.60

LABU vs. BIB - Sharpe Ratio Comparison

The current LABU Sharpe Ratio is 4.01, which is higher than the BIB Sharpe Ratio of 2.38. The chart below compares the historical Sharpe Ratios of LABU and BIB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LABU vs. BIB - Drawdown Comparison

The maximum LABU drawdown since its inception was -99.18%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for LABU and BIB.

Drawdown Indicators

	LABU	BIB	Difference
Max Drawdown Largest peak-to-trough decline	-99.18%	-67.24%	-31.94%
Max Drawdown (1Y) Largest decline over 1 year	-30.70%	-16.92%	-13.78%
Max Drawdown (3Y) Largest decline over 3 years	-78.30%	-45.30%	-33.00%
Max Drawdown (5Y) Largest decline over 5 years	-97.59%	-65.86%	-31.73%
Max Drawdown (10Y) Largest decline over 10 years	-98.96%	-66.20%	-32.76%
Current Drawdown Current decline from peak	-94.92%	-18.88%	-76.04%
Average Drawdown Average peak-to-trough decline	-81.71%	-32.71%	-49.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.91%	5.53%	+5.38%

Volatility

LABU vs. BIB - Volatility Comparison

Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 29.77% compared to ProShares Ultra Nasdaq Biotechnology (BIB) at 13.51%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LABU	BIB	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.77%	13.51%	+16.26%
Volatility (6M) Calculated over the trailing 6-month period	63.11%	31.64%	+31.47%
Volatility (1Y) Calculated over the trailing 1-year period	78.92%	40.47%	+38.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.94%	43.60%	+52.34%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.55%	46.50%	+49.05%

LABU vs. BIB - Expense Ratio Comparison

LABU has a 1.12% expense ratio, which is higher than BIB's 0.95% expense ratio.

Dividends

LABU vs. BIB - Dividend Comparison

LABU's dividend yield for the trailing twelve months is around 0.54%, less than BIB's 0.56% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BIB ProShares Ultra Nasdaq Biotechnology	0.56%	0.77%	1.69%	0.07%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%
LABU Direxion Daily S&P Biotech Bull 3x Shares	0.54%	0.84%	0.35%	0.35%	0.00%	0.00%	0.00%	0.28%	0.64%	0.17%

Frequently Asked Questions

Can I hold both LABU and BIB in my portfolio?

With a correlation of 0.93, LABU and BIB move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, LABU or BIB?

LABU has higher volatility (29.77%) compared to BIB (13.51%). In terms of maximum drawdown, LABU dropped -99.18% vs BIB's -67.24%.

Which ETF is better, LABU or BIB?

On 10-year performance, BIB leads with 9.50% vs -7.38% for LABU. On fees, BIB is cheaper at 0.95% per year. On volatility, BIB has been the lower-risk option at 13.51%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, LABU or BIB?

Over the 10-year period, BIB has performed better with a 9.50% return vs -7.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, LABU or BIB?

BIB is cheaper with a 0.95% expense ratio, compared with 1.12% for LABU.

Which ETF pays a higher dividend yield, LABU or BIB?

BIB has the higher dividend yield at 0.56%, compared with 0.54% for LABU.

What is the main difference between LABU and BIB?

LABU tracks S&P Biotechnology Select Industry Index (300%), while BIB tracks NASDAQ Biotechnology Index (200%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.12% for LABU and 0.95% for BIB.

Which has better risk-adjusted returns?

LABU currently has the higher Sharpe Ratio (4.01 vs 2.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.